Depression treatment is facing stiff decline. The depression treatment market is expected to grow at low CAGR of 2.1% for the forecasted period of 2018-2023. One of the major factors for such low growth is a rapid decline in the revenue of branded drug manufacturers and the growing strength of generic drug manufacturers. The patent cliff has caused a decline in revenues ranging from a few million dollars to billions. The patent expiration and generic drug manufacturers gaining the license to manufacturers have forced many branded drug manufacturers to either stop their R&D or to reduce budgets. There is a very limited number of new drugs in the pipeline. The decline in revenues is majorly due to falling in the price of once-expensive drugs by over 50-90%.  Volume shipment is still high and increasing especially in emerging markets.

Request a free sample of our report on Depression treatment therapy Market: https://www.omrglobal.com/request-sample/depression-treatment-market

 

However, markets for therapies using medical devices such as Vagus nerve stimulation, deep brain stimulation, and smartphones are rising. The devices market is expected to grow at a CAGR of 9.2%. The introduction of virtual reality in the treatment of disorders such as post-traumatic stress disorders are also driving the market.

A full report of Depression treatment therapy Market Is available at https://www.omrglobal.com/industry-reports/depression-treatment-market 

 

Depression treatment therapy Market segmentation

By depression type

Seasonal affective disorder (sad)
Major depression
Dysthymia disorder
Postpartum depression
Atypical depression
Psychotic depression
Bipolar disorder

By drugs type

Selective serotonin reuptake inhibitors
Fluoxetine (prozac)
Sertraline (zoloft)
Escitalopram (lexapro)
Others ssris
Atypical antidepressants
Bupropion (wellbutrin)
Duloxetine (cymbalta)
Venlafaxine (effexor)
Desvenlafexine (pristiq)
Others atypical antidepressants
Tricyclic antidepressants

By depression treatment device

Transcranial magnetic
Deep brain stimulator
Virtual reality therapy
Vagus nerve simulator
Smart phone applications
Others devices

Competitive landscape

Market share analysis
Key company analysis

Regional analysis

North america
United states
Canada
Rest of north america
Europe
United kingdom
France
Germany
Italy
Spain
Rest of europe
Asia pacific
India
China
Japan
Rest of the world

Company profiles

Abbott laboratories
Allergan plc
Astrazeneca
Brain resource company (brc)
Brainsway ltd.
Bristol myers squibb
Cyberonics, inc
Electromedical products international, inc.
Eli lilly and company
Johnson & johnson

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/depression-treatment-market 

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact: 

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404